London
Roots Analysis has announced the addition of “Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030” report to its list of offerings.
Manufacturing live biotherapeutic products is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.
To order this 300+ page report, which features 140+ figures and 125+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html
The research covers detailed profiles brief profiles of several companies (including those listed below); each profile features an overview of the company, its financial information (if available), microbiome-related service portfolio, facilities dedicated to microbiome manufacturing, and an informed future outlook.
Biose®BJP LaboratoriesCapsugel (acquired by Lonza)Cerbios-PharmaCobra Biologics (acquired Cognate Bioservices)Inpac ProbioticsParagon Bioservices (a unit of Catalent Biologics)UAS LabsFor additional details, please visit
https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html or email sales@rootsanalysis.com
You may also be interested in the following titles:
HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030Antibody Contract Manufacturing Market, 2020 – 2030The Human Microbiome Market: Focus on Therapeutics (including gut-brain axis targeting drugs), Diagnostics and Fecal Microbiota Therapies (3rd Edition), 2019-2030Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Sign in to leave a comment.